Table 1.
The relationship between STEAP3 protein expression and clinical characteristics in cervical cancer
| Characteristics | N | STEAP3 protein expression | χ2 | P value | |
|---|---|---|---|---|---|
| Low, n (%) | High, n (%) | ||||
| Age (year) | 0.672 | 0.412 | |||
| < 50 | 48 | 22 (45.8) | 26 (54.2) | ||
| ≥ 50 | 63 | 24 (38.1) | 39 (61.9) | ||
| Type | 0.199 | 0.655 | |||
| SCC | 82 | 35 (42.7) | 47 (57.3) | ||
| Adenocarcinoma | 29 | 12 (41.4) | 17 (58.6) | ||
| Differentiation | 2.459 | 0.117a | |||
| Medium/Low | 12 | 8 (66.7) | 4 (33.3) | ||
| High | 99 | 38 (38.4) | 61 (61.6) | ||
| Stage | 8.605 | 0.003 | |||
| < IB3 | 47 | 27 (57.4) | 20 (42.6) | ||
| ≥IB3 | 64 | 19 (29.7) | 45 (70.3) | ||
| LNM | 3.890 | 0.049a | |||
| Negative | 100 | 45 (45.0) | 55 (55.0) | ||
| Positive | 11 | 1 (9.1) | 10 (90.9) | ||
| LVSI | 4.719 | 0.030 | |||
| Negative | 85 | 40 (47.1) | 45 (52.9) | ||
| Positive | 26 | 6 (23.1) | 20 (76.9) | ||
a, Continuity Correctionb
SCC, squamous cell carcinoma; LNM, lymph node metastasis; LVSI, lymphovascular space invasion